You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Amyloid, Light chain Amyloidosis

Showing 1 - 25 of 6,142
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed/Refractory Multiple Myeloma, Amyloid Light-chain Amyloidosis Trial (SAR445514)

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Amyloid Light-chain Amyloidosis
  • (no location specified)
Apr 20, 2023

Amyloid, Amyloid Cardiomyopathy Trial in Pisa (18F-florbetaben PET/CT)

Recruiting
  • Amyloid
  • Amyloid Cardiomyopathy
  • 18F-florbetaben PET/CT
  • Pisa, Italy
    Fondazione Toscana Gabriele Monasterio
Sep 16, 2023

Amyloidosis, Primary, Cardiomyopathy Trial in Boston (F-18 florbetapir/C-11 acetate PET, MRI, N-13 ammonia PET)

Recruiting
  • Amyloidosis, Primary
  • Cardiomyopathy
  • F-18 florbetapir/C-11 acetate PET
  • +2 more
  • Boston, Massachusetts
    Brigham and Womens' Hospital
Oct 23, 2022

Amyloid, Amyloidosis, AL Amyloidosis Trial in New York (Selinexor, Dexamethasone)

Suspended
  • Amyloid
  • +2 more
  • New York, New York
    Weill Cornell Medicine - Multiple Myeloma Center
May 17, 2022

Left and Right Ventricular Global Strain After Chemotherapy in

Recruiting
  • Amyloid Cardiomyopathy
  • +2 more
  • Left and Right Ventricular Global Strain Imaging
  • Istanbul, Fatih, Turkey
    Istanbul University-Cerrahpasa
Aug 11, 2022

Left Atrial Strain and Supraventricular Arrhythmia Burden in

Recruiting
  • Supraventricular Arrhythmia
  • +3 more
  • Left Atrial Strain Imaging
  • Electrocardiography
  • Istanbul, Turkey
    Istanbul University-Cerrahpasa
Aug 10, 2022

Hereditary Transthyretin Amyloidosis

Recruiting
  • Amyloidosis
  • +6 more
    • Cleveland, Ohio
      Cleveland Clinic
    Mar 11, 2022

    Screening for Systemic Amyloidosis Via the Ligamentum Flavum

    Completed
    • Amyloid
    • +4 more
    • Biopsy
    • Cleveland, Ohio
      Cleveland Clinic
    Dec 21, 2021

    Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in Canada, United States (pomalidomide, bortezomib,

    Active, not recruiting
    • Light Chain Deposition Disease
    • Primary Systemic Amyloidosis
    • Denver, Colorado
    • +4 more
    Jan 20, 2023

    Amyloidosis, Light Chain (AL) Amyloidosis Trial (Bendamustine Hydrochloride, Isatuximab)

    Withdrawn
    • Amyloidosis
    • Light Chain (AL) Amyloidosis
    • (no location specified)
    Dec 29, 2022

    Amyloidosis Trial in Worldwide (Daratumumab, Cyclophosphamide, Bortezomib)

    Recruiting
    • Amyloidosis
    • Duarte, California
    • +46 more
    Aug 5, 2022

    Light Chain (AL) Amyloidosis, CCND1 Translocation, Venetoclax Trial (Venetoclax, Dexamethasone Oral)

    Not yet recruiting
    • Light Chain (AL) Amyloidosis
    • +2 more
    • (no location specified)
    Aug 16, 2023

    Light Chain Amyloidosis Trial (FKC288)

    Not yet recruiting
    • Light Chain Amyloidosis
    • (no location specified)
    Jul 30, 2023

    Light Chain (AL) Amyloidosis Trial in Sacramento (NXC-201 CAR-T)

    Not yet recruiting
    • Light Chain (AL) Amyloidosis
    • NXC-201 CAR-T
    • Sacramento, California
      University of California Davis Medical Center
    Oct 19, 2023

    AL Amyloidosis Trial in Palo Alto, Detroit, Cleveland (CAEL-101, SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD),

    Active, not recruiting
    • AL Amyloidosis
    • Palo Alto, California
    • +2 more
    Dec 6, 2022

    AL Amyloidosis Trial in Scottsdale, Jacksonville, Rochester (procedure, biological, other)

    Not yet recruiting
    • AL Amyloidosis
    • Bone Marrow Biopsy
    • +4 more
    • Scottsdale, Arizona
    • +2 more
    Jun 2, 2023

    AL Amyloidosis, Light Chain (AL) Amyloidosis, Systemic Light Chain Disease Trial in San Francisco (Venetoclax, Dexamethasone,

    Not yet recruiting
    • AL Amyloidosis
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Aug 16, 2022

    AL Amyloidosis Trial in New York (Venetoclax Oral Tablet, 200 mg, FISH assay, Venetoclax Oral Tablet, 400 mg)

    Not yet recruiting
    • AL Amyloidosis
    • Venetoclax Oral Tablet, 200 mg
    • +9 more
    • New York, New York
      New York Presbyterian Hospital/Columbia University Irving Medica
    Jul 11, 2022

    Primary Systemic Amyloidosis, Light Chain Deposition Disease Trial in United States (drug, genetic, other, procedure)

    Active, not recruiting
    Has Results
    • Primary Systemic Amyloidosis
    • Light Chain Deposition Disease
    • Denver, Colorado
    • +6 more
    Aug 24, 2022

    Cardiac Amyloidosis Screening at Trigger Finger Release

    Completed
    • Amyloidosis
    • +3 more
    • Biopsy
    • Cleveland, Ohio
      Cleveland Clinic
    Dec 21, 2021

    Immunoglobulin Light-chain Amyloidosis Trial (Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules

    Not yet recruiting
    • Immunoglobulin Light-chain Amyloidosis
    • Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab
    • Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab
    • (no location specified)
    Mar 18, 2023

    Light Chain (AL) Amyloidosis Trial (STI-6129)

    Not yet recruiting
    • Light Chain (AL) Amyloidosis
    • STI-6129
    • (no location specified)
    Jan 11, 2023

    Amyloidosis; Systemic Trial in Beijing (Daratumumab, Bortezomib, Dexamethasone)

    Active, not recruiting
    • Amyloidosis; Systemic
    • Beijing, China
      Peking Union Medical College Hospital
    May 9, 2022

    Amyloidosis, AL Amyloidosis Trial in Worldwide (ZN-d5)

    Recruiting
    • Amyloidosis
    • AL Amyloidosis
    • Denver, Colorado
    • +1 more
    Jan 18, 2022

    Screening to Improve Survival in AL Amyloidosis

    Recruiting
    • Smoldering Multiple Myeloma
    • Monoclonal Gammopathy of Undetermined Significance
      • Orange, California
      • +5 more
      Nov 16, 2022